Equities

ATI Physical Therapy Inc

ATIP:NYQ

ATI Physical Therapy Inc

Actions
Health CareHealth Care Providers
  • Price (USD)1.56
  • Today's Change-0.03 / -1.89%
  • Shares traded1.98k
  • 1 Year change-79.34%
  • Beta0.2777
Data delayed at least 15 minutes, as of Nov 21 2024 15:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ATI Physical Therapy, Inc. is a healthcare company. The Company is an outpatient physical therapy provider in the United States. The Company specializes in outpatient rehabilitation and adjacent healthcare services, with 896 clinics located in 24 states. It offers a variety of services within its clinics, including physical therapy to treat spine, shoulder, knee and neck injuries or pain; work injury rehabilitation services, including work conditioning and work hardening; hand therapy, and other specialized treatment services. It provides services through its ATI Worksite Solutions (AWS) program, Management Service Agreements (MSA), and Sports Medicine arrangements. Its AWS is an on-site service that provides customized cost-saving injury prevention programs, work-related injury assessment services, wellness offerings and consultations for employers. Its MSA arrangements provide management and physical therapy-related services to physician-owned physical therapy clinics.

  • Revenue in USD (TTM)741.86m
  • Net income in USD-79.62m
  • Incorporated2020
  • Employees6.00k
  • Location
    ATI Physical Therapy Inc790 Remington BoulevardBOLINGBROOK 60440United StatesUSA
  • Phone+1 (702) 844-6111
  • Fax+1 (302) 655-5049
  • Websitehttps://www.atipt.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Selectis Health Inc37.33m-6.17m4.17m574.00------0.1118-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Biocorrx Inc26.61k-4.91m4.59m5.00------172.48-0.5186-0.51860.0028-1.060.0452--0.1606---840.98-291.68----44.6867.13-18,615.11-3,208.40---3.23-----58.31-25.0413.79------
Kindly MD Inc2.88m-2.94m5.41m23.00--1.56--1.88-0.5496-0.54960.53390.58291.113.53107.94125,017.80-113.55---152.92--93.90---102.28--5.43-6.910.054---0.488--36.34------
Medical Care Technologies Inc.0.00-1.07m5.96m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
NewGenIvf Group Ltd0.00-690.85k6.04m----0.1422-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Mangoceuticals Inc755.00k-9.33m6.14m----0.3938--8.13-5.88-5.880.45846.270.092117.97-----113.83---125.71--58.60---1,235.32--0.0653-18.830.0138--8,082.22---361.07------
CompuMed Inc1.78m-151.00k6.19m8.00--47.56--3.48-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
ATI Physical Therapy Inc741.86m-79.62m7.01m6.00k------0.0095-18.57-18.57174.1717.200.7625--8.02123,643.80-5.49---6.39--16.13---7.21----0.19050.8762--9.97--73.20------
Univec Inc-100.00bn-100.00bn7.54m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Inspire Veterinary Partners Inc17.13m-19.33m7.55m156.00------0.4408-134.72-134.724.54-0.6310.816521.61246.52109,778.20-89.79---190.96--19.47---109.98--0.1311-2.741.20--69.56---206.68------
Ontrak Inc11.24m-35.68m7.72m102.00--0.5432--0.6868-10.55-10.553.023.370.5207--21.66110,186.30-123.82-54.80-228.86-73.3764.0053.50-237.77-71.95---2.270.4088---12.20-3.4439.08--99.58--
Xcelerate Inc3.96m-296.19k9.71m1.00--6.98--2.45-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Healthlynked Corp3.32m-6.19m9.87m38.00------2.97-0.0222-0.02220.0119-0.00690.786215.8281.3287,385.27-146.48-119.37-966.37-332.2247.3355.81-186.32-119.260.4586-4.69-----2.3220.4357.08---12.94--
Oncology Institute Inc378.93m-57.46m9.98m800.00--0.6452--0.0263-0.7706-0.77065.080.20491.9129.197.36473,666.30-35.34---44.12--14.1819.54-18.53-9.992.27-7.440.8553--28.4223.43-99,919.12--45.68--
Data as of Nov 21 2024. Currency figures normalised to ATI Physical Therapy Inc's reporting currency: US Dollar USD

Institutional shareholders

8.37%Per cent of shares held by top holders
HolderShares% Held
Knighthead Capital Management LLCas of 30 Sep 2024258.60k5.88%
The Vanguard Group, Inc.as of 30 Sep 202466.14k1.50%
Geode Capital Management LLCas of 30 Sep 202414.11k0.32%
BlackRock Fund Advisorsas of 30 Sep 202411.43k0.26%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 20247.56k0.17%
Northern Trust Global Investments Ltd.as of 30 Sep 20244.67k0.11%
Bank of America, NA (Private Banking)as of 30 Sep 20243.10k0.07%
Nordwand Advisors LLCas of 30 Sep 20241.50k0.03%
Tower Research Capital LLCas of 30 Sep 2024714.000.02%
Group One Trading LLCas of 30 Sep 2024700.000.02%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.